-
Start Preamble
AGENCY:
U.S. Nuclear Regulatory Commission.
ACTION:
Notice of meeting.
SUMMARY:
The U.S. Nuclear Regulatory Commission (NRC) will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on March 11, 2020, to discuss the draft report of the ACMUI Regulatory Guide 8.39 Subcommittee. A phased approach is being conducted by the NRC staff to comprehensively update Regulatory Guide 8.39, “Release of Patients Administered Radioactive Material.” Phase 1 of the revision provides licensees with more detailed instructions to patients before and after they have been administered radioactive material than what is currently provided in Regulatory Guide 8.39. The ACMUI subcommittee's report will include its comments and recommendations on the draft final Phase 1 revisions to Regulatory Guide 8.39. Meeting information, including a copy of the agenda and handouts, will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html. The agenda and handouts may also be obtained by contacting Ms. Kellee Jamerson using the information below.
DATES:
The teleconference meeting will be held on Wednesday, March 11, 2020, 2:00 p.m. to 4:00 p.m. Eastern Time.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Kellee Jamerson, email: Kellee.Jamerson@nrc.gov, telephone: (301) 415-7408.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Public Participation: Any member of the public who wishes to participate in the teleconference should contact Ms. Jamerson using the contact information in FOR FURTHER INFORMATION CONTACT.
Conduct of the Meeting
Dr. Darlene Metter, ACMUI Chairman, will preside over the meeting. Dr. Metter will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting:
1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Jamerson at the contact information listed above. All written statements must be received by March 6, 2020, three business days prior to the meeting, and must pertain to the topic on the agenda for the meeting.
2. Questions and comments from members of the public will be permitted during the meeting at the discretion of the ACMUI Chairman.
3. The draft transcript and meeting summary will be available on ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html on or about April 22, 2020.
This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission's regulations in 10 CFR part 7.
Start SignatureDated: January 17, 2020.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2020-01127 Filed 1-23-20; 8:45 am]
BILLING CODE 7590-01-P
Document Information
- Published:
- 01/24/2020
- Department:
- Nuclear Regulatory Commission
- Entry Type:
- Notice
- Action:
- Notice of meeting.
- Document Number:
- 2020-01127
- Dates:
- The teleconference meeting will be held on Wednesday, March 11, 2020, 2:00 p.m. to 4:00 p.m. Eastern Time.
- Pages:
- 4343-4343 (1 pages)
- PDF File:
- 2020-01127.pdf
- Supporting Documents:
- » Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
- » Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
- » Advisory Committee on the Medical Uses of Isotopes Charter Renewal
- » Advisory Committee on the Medical Uses of Isotopes: Meeting Notice
- » Advisory Committee on the Medical Uses of Isotopes: Meeting Notice